Gyala Therapeutics Launches a Novel CAR-T Therapy Targeting CD84 for Blood Cancers Gyala Therapeutics has introduced a cutting-edge CAR-T therapy, GYA01, aimed at targeting CD84 in leukemia, demonstrating strong preclinical results and promising future clinical trials.

Gyala Therapeutics Launches a Novel CAR-T Therapy Targeting CD84 for Blood Cancers #Spain #Barcelona #CAR-T_therapy #Gyala_Therapeutics #CD84